Chemed (CHE)
(Delayed Data from NYSE)
$554.72 USD
+4.73 (0.86%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $554.72 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value D Growth D Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CHE 554.72 +4.73(0.86%)
Will CHE be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for CHE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CHE
AMED or CHE: Which Is the Better Value Stock Right Now?
CHE Misses on Q3 Earnings, Lowers '24 EPS View, Stock Up
CHE: What are Zacks experts saying now?
Zacks Private Portfolio Services
Chemed (CHE) Lags Q3 Earnings and Revenue Estimates
AMED vs. CHE: Which Stock Is the Better Value Option?
Reasons to Retain Chemed Stock in Your Portfolio Now
Other News for CHE
LRT Capital Management October 2024 Investor Update
Chemed price target lowered to $633 from $697 at RBC Capital
Chemed price target lowered by $64 at RBC Capital, here's why
Chemed Corp (CHE) Q3 2024 Earnings Call Highlights: VITAS Shines Amid Roto-Rooter's Challenges
Chemed Corporation Reports Mixed Q3 2024 Results